PAN India Service 

WHO Certified

Big Pharma vs Big Pharma in court battles over biosimilar drugs

Big Pharma vs Big Pharma in court battles over biosimilar drugs

Big Pharma vs Big Pharma in court battles over biosimilar drugs

Reuters - The line dividing makers of brand-name drugs and copycat medicines is blurring as companies known for innovative treatments queue up to peddle copies of rivals' complex biological medicines.

Leave a Comment

(0 Comments)

Your email address will not be published. Required fields are marked *